Plant-Derived and Botanical Drugs to Reach Nearly $40B by 2022
05. Dezember 2017 14:15 ET
|
BCC Research
WELLESLEY, Mass., Dec. 05, 2017 (GLOBE NEWSWIRE) -- There has been rising interest in botanical drugs, with many players investigating the commercial potential. The global market for plant-derived...